Interim analysis of a randomized Phase III trial comparing complete mesocolic excision (CME) with conventional surgery for right colon cancer showed that CME was associated with a significantly higher lymph node yield (25 vs. 20) and improved surgical quality indicators. No differences were observed in complications, mortality, or surgery duration. Hospital stay was even shorter after CME. These findings support the feasibility and safety of CME, highlighting the importance of further investigation to assess its impact on disease-free survival and long-term outcomes.
Journal Article by Degiuli M, Aguilar AHR (…) Reddavid R et 21 al. in Ann Surg Oncol
© 2023. The Author(s).